UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2011-03, Vol.29 (7), p.825-831

2011

Volltextzugriff (PDF)

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Obstetrics and gynecology (New York. 1953), 2016-09, Vol.128 (3), p.535-542

2016

Volltextzugriff (PDF)

Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women

American journal of obstetrics and gynecology, 2015-01, Vol.212 (1), p.65.e1-65.e5

2015

Volltextzugriff (PDF)

Fenretinide: a novel treatment for endometrial cancer

PloS one, 2014-10, Vol.9 (10), p.e110410

2014

Volltextzugriff (PDF)

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4349-4350

2020

Volltextzugriff (PDF)

The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma

Endocrinology (Philadelphia), 2008-04, Vol.149 (4), p.1942-1950

2008

Volltextzugriff (PDF)

Robotic surgery in gynecologic oncology: Impact on fellowship training

Gynecologic oncology, 2009-08, Vol.114 (2), p.168-172

2009

Volltextzugriff (PDF)

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer

Journal of Gynecologic Oncology, 2013, 24(3), , pp.258-264

2013

Volltextzugriff (PDF)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Gynecologic oncology, 2020-08, Vol.158 (2), p.354-360

2020

Volltextzugriff (PDF)

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Gynecologic oncology, 2012-06, Vol.125 (3), p.572-575

2012

Volltextzugriff (PDF)

Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery

Regional anesthesia and pain medicine, 2011-05, Vol.36 (3), p.271-277

2011

Volltextzugriff (PDF)

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Gynecologic oncology, 2015-08, Vol.138 (2), p.339-342

2015

Volltextzugriff (PDF)

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Gynecologic oncology, 2011-05, Vol.121 (2), p.285-289

2011

Volltextzugriff (PDF)

Is Dexamethasone Associated with Recurrence of Ovarian Cancer?

Anesthesia and analgesia, 2014-06, Vol.118 (6), p.1213-1218

2014

Volltextzugriff (PDF)

Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2110-2114

2003

Volltextzugriff (PDF)

Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells

American journal of obstetrics and gynecology, 2008-09, Vol.199 (3), p.240.e1-240.e8

2008

Volltextzugriff (PDF)

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

Gynecologic oncology, 2013-11, Vol.131 (2), p.362-367

2013

Volltextzugriff (PDF)

A comparison of 2 methods of vaginal cuff closure during robotic hysterectomy

International journal of gynecology and obstetrics, 2013-01, Vol.120 (1), p.99-101

2013

Volltextzugriff (PDF)

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia

Journal of reproductive medicine, 2012-05, Vol.57 (5-6), p.219

2012

Volltextzugriff (PDF)

Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers

JNCI : Journal of the National Cancer Institute, 2014-10, Vol.106 (10)

2014

Volltextzugriff (PDF)

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Gynecologic oncology, 2004-06, Vol.93 (3), p.575-585

2004

Volltextzugriff (PDF)

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

JNCI : Journal of the National Cancer Institute, 2014-10, Vol.106 (10), p.1

2014

Volltextzugriff (PDF)

Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes

Journal of reproductive medicine, 2014-05, Vol.59 (5-6), p.199

2014

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(69)
Science & Technology
(68)
Female
(67)
Life Sciences & Biomedicine
(67)
Obstetrics & Gynecology
(41)
Oncology
(37)
Adult
(34)
Middle Aged
(31)
Biological And Medical Sciences
(29)
Medical Sciences
(29)
Gynecology. Andrology. Obstetrics
(23)
Pregnancy
(23)
Aged
(21)
Tumors
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Neoplasm Staging
(15)
Retrospective Studies
(15)
Treatment Outcome
(15)
Uterine Neoplasms - Pathology
(15)
Chemotherapy
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Barriers to prevention: knowledge of HPV, cervical cancer, and HPV vaccinations among African American women

Fenretinide: a novel treatment for endometrial cancer

Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma

Robotic surgery in gynecologic oncology: Impact on fellowship training

The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy

Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery

Fatal gestational trophoblastic neoplasia: An analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors

Is Dexamethasone Associated with Recurrence of Ovarian Cancer?

Topotecan Is an Active Agent in the First-Line Treatment of Metastatic or Recurrent Endometrial Carcinoma: Eastern Cooperative Oncology Group Study E3E93

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells

A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer

A comparison of 2 methods of vaginal cuff closure during robotic hysterectomy

Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia

Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers

Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53

Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers

Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes

Suchergebnisse filtern